Found 42 matching trials
SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE VĀ® Everolimus Eluting Coronary Stent System
PHASE3The purpose of the SPIRIT IV Clinical Trial is to continue to evaluate the ...
Location
Scottsdale Healthcare
SPIRIT III Clinical Trial of the XIENCE VĀ® Everolimus Eluting Coronary Stent System (EECSS)
PHASE3This study is divided into 5 arms:
1. Randomized Clinical Trial (RCT): Pro...
Location
Baptist Medical Center Princeton
XIENCE VĀ® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study
N/AXIENCE VĀ® India is a prospective, open-label, multi-center, observational, ...
ABSORB PHYSIOLOGY Clinical Investigation
NAThe target enrollment goal for the trial was to enroll 36 subjects. However...
SPIRIT Small Vessel Registry
NATo evaluate the safety and effectiveness of the 2.25 mm XIENCE VĀ® Everolimu...
Location
Scottsdale Healthcare
Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent
PHASE4This is a prospective, randomized, multi center study. Approximately 2700 p...
Location
Onassis cardiac Surgery Centre
Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions
NABingo drug-eluting balloon versus a drug-eluting stent for coronary bifurca...
Location
Multiple Locations
EXecutive RCT: Evaluating XIENCE VĀ® in a Multi Vessel Disease
PHASE4The purpose of this two part study is the assessment of the performance of ...
Location
A.O. San Giovanni di Dio
DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity
NARationale:
The introduction of drug-eluting stents (DES) in the treatment ...
Location
Medisch Centrum Alkmaar
XIENCE VĀ® USA Dual Antiplatelet Therapy (DAPT) Cohort
PHASE4XIENCE V USA is a prospective, multi-center, multi-cohort postapproval stud...
Location
Birmingham Heart Clinic, PC